Similarly, in liver cancer, DPP9-KEAP1 interaction, confirmed by co-immunoprecipitation of endogenous proteins, reduces NRF2 degradation, increasing NQO1 expression and decreasing chemotherapy efficacy. The gene discussed is DPP9; the disease is liver cancer.